Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Pharmacokinetics

• Publication date

  2018-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40262-017-0617-2PMID 29236228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of Lidocaine Hydrochloride Administered with or without Adrenaline for the Paravertebral Brachial Plexus Block in Dogs

  2017cited by this paper
• Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions

  2016cited by this paper
• Pharmacodynamic response modelling of arterial blood pressure in adult volunteers during propofol anaesthesia.

  2015cited by this paper
• Pharmacokinetic–pharmacodynamic modelling in anaesthesia

  2015cited by this paper
• Modeling the Anesthetic Effect of Ropivacaine after a Femoral Nerve Block in Orthopedic Patients: A Population Pharmacokinetic–Pharmacodynamic Analysis

  2015cited by this paper
• Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.

  2015cited by this paper
• Mixed Effects Models for the Population Approach: Models, Tasks, Methods, and Tools

  2015influential reference
• Pharmacométrie de la ropivacaïne suivant l’anesthésie locorégionale chez les patients orthopédiques : caractérisation de l’intensité et de la durée du bloc sensitif

  2014cited by this paper
• Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.

  2014influential reference
• Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods

  2013influential reference
• Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.

  2013cited by this paper
• Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor.

  2013cited by this paper
• Ropivacaine

  2012cited by this paper
• Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

  2011cited by this paper
• Determination and Comparison of Graded Dose–Response Curves for Epidural Bupivacaine and Ropivacaine for Analgesia in Laboring Nulliparous Women

  2010cited by this paper
• Population Pharmacokinetic–Pharmacodynamic Modeling of Epidural Anesthesia

  2008influential reference
• Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

  2008cited by this paper
• Estimation of Population Pharmacokinetic Parameters of Saquinavir in HIV Patients with the MONOLIX Software

  2007cited by this paper
• Pharmacokinetic-Pharmacodynamic Modeling and Simulation.

  2007influential reference
• Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

  2007cited by this paper
• The Effect of Age on the Systemic Absorption and Systemic Disposition of Ropivacaine after Epidural Administration

  2006cited by this paper
• Sensitive bioassay of bupivacaine in human plasma by liquid-chromatography-ion trap mass spectrometry.

  2005cited by this paper
• Intrathecal drug spread.

  2004influential reference
• Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications

  2002cited by this paper
• Spinal Anesthesia with Tetracaine in 7.5% or 0.75% Glucose in Adolescents and Adults

  2001cited by this paper
• Spinal Ropivacaine for Cesarean Section: A Dose-finding Study

  2001cited by this paper
• Intrathecal Anesthesia: Ropivacaine Versus Bupivacaine

  2000cited by this paper
• Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers.

  1999cited by this paper
• Recent Advances in the Pharmacokinetics of Local Anaesthetics

  1999cited by this paper
• A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

  1999cited by this paper
• Lumbosacral Cerebrospinal Fluid Volume Is the Primary Determinant of Sensory Block Extent and Duration during Spinal Anesthesia

  1998influential reference
• Cerebrospinal Fluid Pharmacokinetics and Pharmacodynamics of Intrathecal Neostigmine Methylsulfate in Humans

  1998cited by this paper
• Stability and Performance of a Population Pharmacokinetic Model

  1997cited by this paper
• Spread of subarachnoid hyperbaric amethocaine in adolescents.

  1996cited by this paper
• Population Pharmacodynamic Modeling and Covariate Detection for Central Neural Blockade

  1996cited by this paper
• Magnetic Resonance Imaging of Cerebrospinal Fluid Volume and the Influence of Body Habitus and Abdominal Pressure

  1996cited by this paper
• Spinal Bupivacaine in Ambulatory Surgery: The Effect of Saline Dilution

  1996cited by this paper
• High dose spinal anaesthesia with glucose free 0.5% bupivacaine 25 and 30 mg

  1995cited by this paper
• Pharmacokinetics of Ropivacaine and Bupivacaine for Bilateral Intercostal Blockade in Healthy Male Volunteers

  1994cited by this paper
• Spinal Anesthesia for Cesarean Delivery: A Comparison of Two Doses of Hyperbaric Bupivacaine

  1993cited by this paper
• Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

  1992cited by this paper
• Pharmacodynamic modeling of anesthetic EEG drug effects.

  1992cited by this paper
• Clinical Pharmacokinetics of Epidural and Spinal Anaesthesia

  1989cited by this paper
• Disposition Kinetics of Ropivacaine in Humans

  1989cited by this paper
• Spinal analgesia with hyperbaric bupivacaine: influence of age.

  1988cited by this paper
• Spinal anaesthesia with hyperbaric bupivacaine. Effects of age on neural blockade and pharmacokinetics.

  1988cited by this paper
• Qualitative and quantitative morphology of human sural nerve at different ages.

  1985influential reference
• Distribution of Local Anesthetic Solutions within the Subarachnoid Space

  1985influential reference
• Spinal analgesia using bupivacaine 0·5% plain Variation in the extent of the block with patient age

  1981cited by this paper
• Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data

  1981cited by this paper
• Age‐related changes in peripheral and central nerve conduction in man

  1979influential reference
• Tests of statistical hypotheses concerning several parameters when the number of observations is large

  1943cited by this paper

• A population pharmacokinetic study of ampicillin therapy in hospitalized foals.

  2026cites this paper
• Predicting cerebral acetylcholine dynamics with huperzine A pharmacokinetics in blood via mPBPK-PD modeling.

  2026cites this paper
• The Influence of Dexmedetomidine Added to Ropivacaine on Its Pharmacokinetic and Pharmacodynamic Effects During Lumbar Plexus Block.

  2025cites this paper
• Amikacin use in critically ill patients requiring renal replacement therapy: the AMIDIAL-ICU study

  2025cites this paper
• Ropivacaine combined with MNP in mouse anesthesia

  2023cites this paper
• Effect of single spinal anesthesia with two doses ropivacaine on urinary retention after hemorrhoidectomy in male patients

  2023cites this paper
• Development and Validation of a Non-Targeted Screening Method for Most Psychoactive, Analgesic, Anaesthetic, Anti-Diabetic, Anti-Coagulant and Anti-Hypertensive Drugs in Human Whole Blood and Plasma Using High-Resolution Mass Spectrometry

  2023cites this paper
• A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis.

  2023cites this paper
• Ropivacaine pharmacokinetics in the arterial and venous pools after ultrasound-guided continuous thoracic paravertebral nerve block

  2023cites this paper
• Negative Impact of ST-Segment Elevation Myocardial Infarction and Morphine Dose on Ticagrelor Uptake and Pharmacodynamics: A Population PK/PD Analysis of Pooled Individual Participant Data

  2023cites this paper
• The Perception of the Anesthesiologist Among the Medical, Paramedical and Administrative Staff

  2022cites this paper
• Effects of different doses of ropivacaine on postoperative analgesia, incidence of complications and stress factors in patients undergoing total knee arthroplasty

  2022cites this paper
• The feasibility and safety of cocktail treatment of triple anti-inflammatory agents loaded with gelatin sponge promotes early recovery after posterior percutaneous endoscopic cervical discectomy

  2022cites this paper
• External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab

  2021cites this paper
• Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.

  2021cites this paper
• Different Concentrations of Ropivacaine under Ultrasound Guidance on Quadratus Lumbar Muscle Nerve Block in Elderly Patients with Hip Replacement

  2021cites this paper
• Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia

  2020cites this paper
• Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study

  2020cites this paper
• Ticagrelor Prevents Endothelial Cell Apoptosis through the Adenosine Signalling Pathway in the Early Stages of Hypoxia

  2020cites this paper
• Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

  2020cites this paper
• Dexmedetomidine versus sufentanil with high‐ or low‐concentration ropivacaine for labor epidural analgesia: A randomized trial

  2019cites this paper
• Intravenous single administration of amiodarone and breastfeeding

  2019cites this paper
• Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs

  2019cites this paper
• Failed spinal anaesthesia by intrathecal ropivacaine

  2019cites this paper
• COMPARING INTRAVITREAL AIR AND GAS FOR THE TREATMENT OF VITREOMACULAR TRACTION.

  2019cites this paper
• Intratumoral Distribution of YSNSG Cyclopeptide in a Mouse Melanoma Model using Microdialysis.

  2019cites this paper
• Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

  2019cites this paper
• Population pharmacokinetics of articaine with 1:200,000 epinephrine during third molar surgery and simulation of high‐dose regimens

  2018cites this paper
• Challenges and innovations of drug delivery in older age

  2018cites this paper
• Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.

  2018cites this paper